Vinblastine (VLB), bleomycin (BLEO), cis
โ
Lynn G. Feun; Michael K. Samson; Ronald L. Stephens
๐
Article
๐
1980
๐
John Wiley and Sons
๐
English
โ 698 KB
Nineteen patients considered to have metastatic primary extragonadal germ cell cancer were entered on a Phase I1 chemotherapy study using as induction therapy a combination of vinhlastine (VLB) 12 mg/m2 day I , bleomycin (BLEO) 15 U/m2 I.V. or I.M. twice weekly, and cis-diamminedichloroplatinum (DDP